Literature DB >> 12123458

Genes of non-typeable Haemophilus influenzae expressed during interaction with human epithelial cell lines.

Peter van Ulsen1, Muriel van Schilfgaarde, Jacob Dankert, Henk Jansen, Loek van Alphen.   

Abstract

Non-typeable Haemophilus influenzae may infect the lower respiratory airways of chronic obstructive pulmonary disease patients. We characterized genes of non-typeable H. influenzae expressed during interaction with two human respiratory tract-derived epithelial cell lines. A library of 8000 clones was constructed in H. influenzae Rd (rec1) by cloning chromosomal fragments upstream of a promoterless cat gene. Exposure of this library to NCI-H292 epithelial cell layers in the presence of chloramphenicol (Cam) resulted in survival of bacteria expressing cat. A total of 52 clones were selected that were resistant to Cam in the presence of epithelial cells of cell line NCI-H292. These did not (n = 42) or hardly grow (n = 10) on sBHI plates containing Cam and were sensitive to Cam in cell culture medium alone. All clones, moreover, survived Cam in the presence of Hep2 epithelial cell layers. Sequence analysis showed that four clones contained sequences without homology to Rd or any other sequence, and therefore contained promoters and parts of open reading frames (ORFs) of novel genes. The other 48 clones were homologous to Rd, and characterization was based upon this genome. Six different functional classes were distinguished: (i) metabolic processes; (ii) stress response; (iii) gene expression; (iv) cell envelope biosynthesis; (v) DNA-related processes and cell division; and (vi) ORFs encoding proteins of unknown function. The contribution of identified genes to non-typeable H. influenzae adaptation to the epithelial cell environment is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123458     DOI: 10.1046/j.1365-2958.2002.03025.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  7 in total

Review 1.  Haemophilus influenzae: genetic variability and natural selection to identify virulence factors.

Authors:  Janet R Gilsdorf; Carl F Marrs; Betsy Foxman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae.

Authors:  Kai Shen; Patricia Antalis; John Gladitz; Sameera Sayeed; Azad Ahmed; Shujun Yu; Jay Hayes; Sandra Johnson; Bethany Dice; Richard Dopico; Randy Keefe; Benjamin Janto; William Chong; Joseph Goodwin; Robert M Wadowsky; Geza Erdos; J Christopher Post; Garth D Ehrlich; Fen Z Hu
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Nontypeable Haemophilus influenzae gene expression induced in vivo in a chinchilla model of otitis media.

Authors:  Kevin M Mason; Robert S Munson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

4.  Maturation of molybdoenzymes and its influence on the pathogenesis of non-typeable Haemophilus influenzae.

Authors:  Rabeb Dhouib; Dk S M Pg Othman; Ama-Tawiah Essilfie; Phil M Hansbro; Jeffrey O Hanson; Alastair G McEwan; Ulrike Kappler
Journal:  Front Microbiol       Date:  2015-11-05       Impact factor: 5.640

5.  Comparative genomic analysis reveals distinct genotypic features of the emerging pathogen Haemophilus influenzae type f.

Authors:  Yu-Ching Su; Fredrik Resman; Franziska Hörhold; Kristian Riesbeck
Journal:  BMC Genomics       Date:  2014-01-18       Impact factor: 3.969

Review 6.  Respiratory tract infections and pneumonia.

Authors:  Susan McChlery; Gordon Ramage; Jeremy Bagg
Journal:  Periodontol 2000       Date:  2009-02       Impact factor: 7.589

7.  Haemophilus influenzae P4 Interacts With Extracellular Matrix Proteins Promoting Adhesion and Serum Resistance.

Authors:  Yu-Ching Su; Oindrilla Mukherjee; Birendra Singh; Oskar Hallgren; Gunilla Westergren-Thorsson; Derek Hood; Kristian Riesbeck
Journal:  J Infect Dis       Date:  2015-07-07       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.